RAIADROGASIL (RADL3) Main Indicators
Company Basic DataCompany | RAIADROGASIL |
Corporate Name | RAIA DROGASIL S.A. |
Registration Status | ATIVO |
Issuer Status | FASE OPERACIONAL |
Listing Segment | Novo Mercado |
Activity | Comércio de produtos farmacêuticos. perfumaria e afins. |
Share | RADL3 |
Quote Date | 12/06/2024 |
Share Type | ON |
Last Closing | R$ 24.14 |
Quotation Factor | 1 Share |
Financial Volume | R$ 164.41 M |
Last Statement | ITR - 09/30/2024 |
Sector | Saúde |
Subsector | Comércio e Distribuição |
Segment | Medicamentos e Outros Produtos |
Participation Indexes | GPTW, IBOVESPA, IBRA, IBRX, IBRX50, ICO2, ICON, IGC, IGCT, IGNM, ISE, ITAG, IVBX, MLCX |
Updated 12/08/2024 |
Relative Prices, Market Cap, EV, and Dividend Yield | |
---|
Price/Earnings | 37.35 |
Price/SBV | 6.58 |
Price/Net Sales | 1.10 |
Price/CFO | 17.58 |
Price/FCF | 37.26 |
Price/Total Assets | 1.89 |
Price/EBIT | 17.76 |
Price/Working Capital | 11.55 |
Price/NCAV | -3.44 |
EV/EBIT | 18.99 |
EV/EBITDA | 10.72 |
EV/Net Sales | 1.18 |
EV/CFO | 18.79 |
EV/FCF | 39.83 |
EV/Total Assets | 2.02 |
Company Market Cap | R$ 41.47 B |
Enterprise Value | R$ 44.34 B |
Current Financial Statement Date | 09/30/2024 |
Current Share Price | R$ 24.14 |
Share Price Date | 12/06/2024 |
Dividend Yield | 1.51% |
Summary Income Statement Last 12 Months | |
---|
Net Revenue | R$ 37.70 B |
Gross Result | R$ 11.25 B |
EBIT | R$ 2.34 B |
Depreciation and Amortization | - R$ 1.80 B |
EBITDA | R$ 4.14 B |
Net Profit | R$ 1.11 B |
Net Profit/Share | R$ 0.65 |
Summary Income Statement Last Quarter | |
---|
Net Revenue | R$ 9.99 B |
Gross Result | R$ 2.97 B |
EBIT | R$ 679.00 M |
Depreciation and Amortization | - R$ 501.91 M |
EBITDA | R$ 1.18 B |
Net Profit | R$ 335.02 M |
Profit/Share | R$ 0.20 |
Stock Price and Stock Volume BehaviorLowest Price 52 weeks | R$ 23.98 |
Highest Price 52 weeks | R$ 29.92 |
Variation 2024 | -16.50% |
Variation 1 year | -13.48% |
Variation 2 years(total) | 8.04% |
Variation 2 years(yearly) | 3.94% |
Variation 3 years(total) | 11.72% |
Variation 3 years(yearly) | 3.76% |
Variation 4 years(total) | 8.48% |
Variation 4 years(yearly) | 2.05% |
Variation 5 years(total) | 25.70% |
Variation 5 years(yearly) | 4.68% |
Average Daily Volume (3 months) | R$ 165.71 M |
Updated 12/08/2024 |
Returns, Margins, and Other Measures | |
---|
Return on Initial Tangible Capital | 15.73% |
Return on Initial Invested Capital | 18.72% |
Pre-Tax Return on Initial Tangible Capital | 23.84% |
Pre-Tax Return on Initial Invested Capital | 28.37% |
Return on Initial Shareholder´s Equity | 19.40% |
Return on Initial Asset | 5.73% |
Gross Margin | 29.83% |
Net Margin | 2.95% |
EBIT Margin | 6.19% |
EBITDA Margin | 10.97% |
Initial Asset Turnover | 1.94 |
Financial Leverage | 3.48 |
Liabilities/Net Worth | 2.48 |
Net Debt/EBITDA | 0.69 |
Summary Balance Sheet | |
---|
Cash and Cash Equivalents | R$ 410.51 M |
Total Assets | R$ 21.96 B |
Short-Term Debt | R$ 619.04 M |
Long-Term Debt | R$ 2.66 B |
Gross Debt | R$ 3.27 B |
Net Debt | R$ 2.86 B |
Shareholder´s Equity | R$ 6.30 B |
Share Book Value | R$ 3.67 |
Common Shares | 1,718,007,200 |
Preferred Shares | 0 |
Total | 1,718,007,200 |
Common Shares in Treasury | 2,880,891 |
Preferred Shares in Treasury | 0 |
Total in Treasury | 2,880,891 |
Common Shares (Except Treasury) | 1,715,126,309 |
Preferred Shares (Except Treasury) | 0 |
Total (Except Treasury) | 1,715,126,309 |
Summary Cash Flow Statement Last 12 Months | |
---|
Operating Cash Flow | R$ 2.36 B |
Cash Flow from Investments | - R$ 1.25 B |
Financing Cash Flow | - R$ 1.30 B |
Increase (Reduction) in Cash and Equivalents | - R$ 183.08 M |
Summary Cash Flow Statement Last Quarter | |
---|
Operating Cash Flow | R$ 777.10 M |
Cash Flow from Investments | - R$ 369.19 M |
Financing Cash Flow | - R$ 367.06 M |
Increase (Reduction) in Cash and Equivalents | R$ 40.85 M |
Experimental CAPEX and Free Cash Flow Calculation | |
---|
CAPEX 3 months | - R$ 369.19 M |
Free Cash Flow 3 months | R$ 407.91 M |
CAPEX 12 months | - R$ 1.25 B |
Free Cash Flow 12 months | R$ 1.11 B |